Palo Alto Investors »

Travere Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2023-12-31 $995k 111k 8.99
2023-09-30 $1.5M 166k 8.94
2023-06-30 $2.6M 166k 15.36
2023-03-31 $3.7M 166k 22.49
2022-12-31 $3.5M 166k 21.03
2022-09-30 $4.1M 166k 24.64
2022-06-30 $4.0M 166k 24.23
2022-03-31 $4.3M 166k 25.77
2021-12-31 $5.2M 166k 31.04
2021-09-30 $4.0M 166k 24.25
2021-06-30 $2.4M 166k 14.59
2021-03-31 $4.1M 166k 24.97
2020-12-31 $4.3M 158k 27.26